Pharmaceutical composition for retarding excessive platelet aggr

Details Pharmaceutical composition for retarding excessive platelet aggr Pharmaceutical composition for retarding excessive platelet aggr

1974-06-11

1983-02-01

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

424212, A61K 3166, A61K 3748

Patent

active

043715214

ABSTRACT:
The invention provides a method of treating thrombo-embolic conditions, stress and/or visceral cellular insufficiency in mammals, the method comprising administering to the mammal effective amounts of creatine-phosphate and creatine-phosphokinase. The invention also provides a pharmaceutical composition suitable for use it the method.

REFERENCES:
patent: 3539625 (1970-11-01), Nordmann et al.
Chemical Abstracts 68:112705u (1968).
Gaarder et al., 192 Nature (Lond.) 531-532 (1961).
Born, 194 Nature (Lond.) 927-928 (1962).
Nordoy et al., 1 Scand. J. Hemat., 16-25 (1964).
Rozenberg et al.-Biochemica et Biophysica ACTA, pp. 280-288 (1968).
The Enzymes, Ed. Boyer et al. vol. 6 (1962), chapter 31, pp. 516-520.
Platelets: Product, Function, Transfusion & Storage; Izrael et al., pp. 187-196 (1974).

Affiliated with

Also associated with

Rating

Pharmaceutical composition for retarding excessive platelet aggr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for retarding excessive platelet aggr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for retarding excessive platelet aggr will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2407356